STING1 and severe combined immunodeficiency: Heterozygous V154M STING (equivalent to V155M in patients) and heterozygous STING N153S (equivalent to N154S in patients) mouse strains both display severe combined immunodeficiency disease (SCID) phenotype and thymocytes impairment at early stages (72–74).